Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations and Immune Infiltrate Characterization : the UTOPIC Project

NCT07302074 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT07302074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07302074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations and Immune Infiltrate Characterization : the UTOPIC Project
Lead sponsor
University Hospital, Brest
Phase
Not applicable
Overall status
Recruiting
Start date
March 27, 2026
Completion date
March 3, 2031
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immune checkpoint inhibitor related inflamamtory arthritis, inflammatory arthritis, rare auto-immune diseases